Deciphering the kidney hemodynamic effects of SGLT2 inhibition: translating insights from rats to humans in type 2 diabetes
Kidney International · 2024
DOI: 10.1016/j.kint.2024.06.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2024. Verfasst von Phoom Narongkiatikhun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA; Division of Nephrology, Department of Internal Medicin…. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Hemodynamics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The attenuation of glomerular hyperfiltration is posited to be a principal mechanism underlying the kidney protective effects of sodium-glucose cotransporter-2 (SGLT2) inhibitors in diabetic kidney disease. Notably, the impact of SGLT2 inhibitors on kidney hemodynamic function has been posited to vary between type 1 and type 2 diabetes. The study by Wada et al. documents that in an animal model of type 2 diabetes, SGLT2 inhibitors mitigate glomerular hyperfiltration predominantly through afferent arteriolar constriction, a process mediated by the adenosine/A1 receptor pathway. This observation is consistent with mechanisms identified in type 1 diabetes, arguing for similar methods in type 1 and 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA; Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA. Electronic address: pettermb@uw.edu.
Zitieren
APA
Narongkiatikhun, P., & Bjornstad, P. (2024). Deciphering the kidney hemodynamic effects of SGLT2 inhibition: translating insights from rats to humans in type 2 diabetes. Kidney International. https://doi.org/10.1016/j.kint.2024.06.018
Vancouver
Narongkiatikhun P, Bjornstad P. Deciphering the kidney hemodynamic effects of SGLT2 inhibition: translating insights from rats to humans in type 2 diabetes. Kidney International. 2024. doi:10.1016/j.kint.2024.06.018
BibTeX
@article{Narongkiatikhun2024,
author = {Narongkiatikhun, Phoom and Bjornstad, Petter},
title = {Deciphering the kidney hemodynamic effects of SGLT2 inhibition: translating insights from rats to humans in type 2 diabetes},
journal = {Kidney International},
year = {2024},
doi = {10.1016/j.kint.2024.06.018}
}
EUVIMED